163 related articles for article (PubMed ID: 35669899)
1. Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review.
Miyamoto R; Ogura T; Takahashi A; Ishida H; Matsudaira S; Amikura K; Suzuki Y; Shimizu S; Kihara A; Kanda H; Kawashima Y
Int Cancer Conf J; 2022 Jul; 11(3):188-195. PubMed ID: 35669899
[TBL] [Abstract][Full Text] [Related]
2. Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery.
Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Nakadai E; Kishimoto T; Nakatani Y; Yoshidome H; Miyazaki M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1093-9. PubMed ID: 26240009
[TBL] [Abstract][Full Text] [Related]
3. Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case.
Tsunematsu M; Haruki K; Sakamoto T; Uwagawa T; Shiba H; Yanaga K
Surg Case Rep; 2019 Jun; 5(1):103. PubMed ID: 31236705
[TBL] [Abstract][Full Text] [Related]
4. Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report.
Takayanagi R; Takano S; Sugiura K; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Kato A; Miyazaki M; Ohtsuka M
Surg Case Rep; 2017 Nov; 3(1):116. PubMed ID: 29164423
[TBL] [Abstract][Full Text] [Related]
5. Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.
Wakasa Y; Toyoki Y; Kusumi T; Kameyama Y; Odagiri T; Jin H; Nakai M; Aoki K; Kawashima H; Endo M
Surg Case Rep; 2022 Mar; 8(1):50. PubMed ID: 35332404
[TBL] [Abstract][Full Text] [Related]
6. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
[TBL] [Abstract][Full Text] [Related]
7. Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report.
Miura Y; Ashida R; Sugiura T; Ohgi K; Yamada M; Otsuka S; Todaka A; Uesaka K
Surg Case Rep; 2022 Jan; 8(1):20. PubMed ID: 35079922
[TBL] [Abstract][Full Text] [Related]
8. Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study.
Matsuyama R; Morioka D; Mori R; Hiratani S; Yabushita Y; Ota Y; Kumamoto T; Taniguchi K; Endo I
Cancer Chemother Pharmacol; 2018 May; 81(5):949-955. PubMed ID: 29594362
[TBL] [Abstract][Full Text] [Related]
9. Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report.
Matsubara T; Nishida T; Tomimaru Y; Yamamoto M; Hayashi S; Nakajima S; Fukui K; Dono K; Adachi S; Ioka T; Kanai M; Inada M
Mol Clin Oncol; 2016 Dec; 5(6):757-761. PubMed ID: 28101354
[TBL] [Abstract][Full Text] [Related]
10. Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin.
Dierks J; Gaspersz MP; Belkouz A; van Vugt JLA; Coelen RJS; de Groot JWB; Ten Tije AJ; Meijer WG; Pruijt JFM; van Voorthuizen T; van Spronsen DJ; Rentinck M; Ten Oever D; Smit JM; Otten HM; van Gulik TM; Wilmink JW; Groot Koerkamp B; Klümpen H
Acta Oncol; 2018 Jun; 57(6):807-812. PubMed ID: 29265948
[TBL] [Abstract][Full Text] [Related]
11. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M
Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
[TBL] [Abstract][Full Text] [Related]
12. Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathological complete response to primary tumor and intrahepatic metastasis treated by gemcitabine plus cisplatin chemotherapy and radical surgery.
Shibata Y; Sudo T; Tazuma S; Tazawa H; Suzuki T; Onoe T; Shimizu Y; Tashiro H; Kuraoka K; Takahashi S
Clin J Gastroenterol; 2023 Feb; 16(1):81-86. PubMed ID: 36239900
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
Siebenhüner AR; Seifert H; Bachmann H; Seifert B; Winder T; Feilchenfeldt J; Breitenstein S; Clavien PA; Stupp R; Knuth A; Pestalozzi B; Samaras P
BMC Cancer; 2018 Jan; 18(1):72. PubMed ID: 29325521
[TBL] [Abstract][Full Text] [Related]
14. Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer.
Nakamura I; Hatano E; Baba H; Kamei K; Wada H; Shimizu J; Kanai M; Yoshimura K; Nagano H; Ioka T
Ann Gastroenterol Surg; 2023 Nov; 7(6):1009-1020. PubMed ID: 37927929
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Clinical Course in a Population of Patients with Biliary Tract Cancer Diagnosed as Unresectable After Portal Vein Embolization: A Case Series.
Imamura H; Adachi T; Matsushima H; Ishimaru H; Fukumoto M; Yoshino K; Matsuguma K; Matsumoto R; Hara T; Soyama A; Hidaka M; Eguchi S
Kurume Med J; 2024 Mar; ():. PubMed ID: 38508738
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
17. [A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1].
Ogura N; Hoshino M; Hayashi T; Odaira M; Harada H; Hirose S; Funakoshi S
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1665-1667. PubMed ID: 36733169
[TBL] [Abstract][Full Text] [Related]
18. Curative Resection After Gemcitabine, Cisplatin and S-1 Chemotherapy for Initially Unresectable Biliary Duct Cancer: A Case Report.
Furukawa K; Uwagawa T; Sakamoto T; Shiba H; Tsutsumi J; Yanaga K
Anticancer Res; 2015 Jul; 35(7):4203-6. PubMed ID: 26124379
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study.
Feng K; Liu Y; Zhao Y; Yang Q; Dong L; Liu J; Li X; Zhao Z; Mei Q; Han W
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487569
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
Tan ES; Cao B; Kim J; Al-Toubah TE; Mehta R; Centeno BA; Kim RD
Cancer; 2021 Apr; 127(8):1293-1300. PubMed ID: 33289918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
